Sign in
4

Changes in Ownership

Telomir Pharmaceuticals, Inc. Filed Acc 0001493152-24-034370

Options or other derivatives

  • CEO & Chairman acquired 1,960,170 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Aminov Erez · CEO & Chairman

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-08-27 Grant or award : show line 1 in the form Incentive Stock Options (right to buy) +1,960,170 1,960,170 D
Loading xslF345X05/ownership.xml…